PubRank

Maria Cristina Breschi

Author PubWeight™ 19.35‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Inhibitors of the renal outer medullary potassium channel: a patent review. Expert Opin Ther Pat 2015 1.26
2 Hydrogen sulphide: novel opportunity for drug discovery. Med Res Rev 2010 1.11
3 The role of nitric oxide in anthracycline toxicity and prospects for pharmacologic prevention of cardiac damage. FASEB J 2004 1.02
4 Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther 2007 1.01
5 Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 2003 1.01
6 Vasorelaxing effects of flavonoids: investigation on the possible involvement of potassium channels. Naunyn Schmiedebergs Arch Pharmacol 2004 0.97
7 CB1- and CB2-cannabinoid receptor-independent lipolysis induced by WIN 55,212-2 in male rat adipocytes. Naunyn Schmiedebergs Arch Pharmacol 2003 0.94
8 Relationship between gestational diabetes mellitus and low maternal birth weight. Diabetes Care 2002 0.94
9 Gastrin promotes human colon cancer cell growth via CCK-2 receptor-mediated cyclooxygenase-2 induction and prostaglandin E2 production. Br J Pharmacol 2005 0.90
10 Drug-induced block of cardiac HERG potassium channels and development of torsade de pointes arrhythmias: the case of antipsychotics. J Pharm Pharmacol 2005 0.88
11 Cannabinoid derivatives induce cell death in pancreatic MIA PaCa-2 cells via a receptor-independent mechanism. FEBS Lett 2006 0.85
12 Effects of peroxisome proliferator-activated receptor-γ agonists on the generation of microparticles by monocytes/macrophages. Cardiovasc Res 2012 0.83
13 Hormonal influence on the release of endothelial nitric oxide: gender-related dimorphic sensitivity of rat aorta for noradrenaline. J Pharm Pharmacol 2002 0.83
14 Rosiglitazone reverses salbutamol-induced β(2) -adrenoceptor tolerance in airway smooth muscle. Br J Pharmacol 2011 0.83
15 Pharmacodynamic hybrids coupling established cardiovascular mechanisms of action with additional nitric oxide releasing properties. Curr Pharm Des 2009 0.80
16 Synthesis and biological evaluation of 5-membered spiro heterocycle-benzopyran derivatives against myocardial ischemia. Eur J Med Chem 2011 0.79
17 Effects of K openers on the QT prolongation induced by HERG-blocking drugs in guinea-pigs. J Pharm Pharmacol 2010 0.78
18 Montelukast prevents microparticle-induced inflammatory and functional alterations in human bronchial smooth muscle cells. Pharmacol Res 2013 0.78
19 Enhancer and competitive allosteric modulation model for G-protein-coupled receptors. J Theor Biol 2010 0.78
20 AM251 induces apoptosis and G2/M cell cycle arrest in A375 human melanoma cells. Anticancer Drugs 2015 0.76
21 Therapeutic potential of sulindac hydroxamic acid against human pancreatic and colonic cancer cells. Eur J Med Chem 2010 0.76
22 Protective effect of high-dose montelukast on salbutamol-induced homologous desensitisation in airway smooth muscle. Pulm Pharmacol Ther 2013 0.76
23 New chitosan derivatives for the preparation of rokitamycin loaded microspheres designed for ocular or nasal administration. J Pharm Sci 2009 0.76
24 Structure-activity relationships on purine and 2,3-dihydropurine derivatives as antitubercular agents: a data mining approach. Chem Biol Drug Des 2011 0.75
25 R+-methanandamide inhibits tracheal response to endogenously released acetylcholine via capsazepine-sensitive receptors. Eur J Pharmacol 2003 0.75
26 Role of cyclooxygenase isoforms and nitric-oxide synthase in the modulation of tracheal motor responsiveness in normal and antigen-sensitized Guinea pigs. J Pharmacol Exp Ther 2006 0.75
27 Effects of cannabinoids on non-adrenergic non-cholinergic-mediated relaxation in guinea-pig trachea. Eur J Pharmacol 2003 0.75
28 Spirotetrahydronaphthalene analogues of sympathomimetic catecholamines. Synthesis and adrenergic activity of 5,6- and 6,7-dihydroxy-3,4-dihydrospiro[naphthalen-1 (2H)-3'-piperidines]. J Pharm Pharmacol 2002 0.75
29 Synthesis and in-vitro antitumour activity of new naphthyridine derivatives on human pancreatic cancer cells. J Pharm Pharmacol 2009 0.75